Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016947771> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W3016947771 endingPage "687.e18" @default.
- W3016947771 startingPage "687.e13" @default.
- W3016947771 abstract "For marker-negative clinical stage (CS) IIA nonseminomatous germ cell tumor (NSGCT), National Comprehensive Cancer Network and American Urological Association guidelines recommend either retroperitoneal lymph node dissection (RPLND) or induction chemotherapy. The goal is cure with one form of therapy. We evaluated national practice patterns in the management of CSIIA NSGCT and utilization of secondary therapies. The National Cancer Data Base was used to identify 400 men diagnosed with marker negative CSIIA NSGCT between 2004 and 2014 treated with RPLND or chemotherapy. Trends in the utilization of initial and adjuvant treatment (chemotherapy only, RPLND only, RPLND with adjuvant chemotherapy, and postchemotherapy RPLND) were analyzed. Of the 400 cases, 233 (58%) underwent induction chemotherapy with surveillance, 51 (20%) underwent RPLND with surveillance, 89 (22%) underwent RPLND followed by adjuvant chemotherapy, and 14 (4%) underwent induction chemotherapy followed by RPLND. Thirty percent of patients received dual therapy. After RPLND with pN1 staging, 43 (61%) underwent adjuvant chemotherapy. The pN0 rate after primary RPLND was 22%. Five year overall survival ranged from 95% to 100% based on initial treatment choice. For marker negative CS IIA nonseminoma, dual, therapy, and treatment with chemotherapy is common. With low volume retroperitoneal disease resected at RPLND, adjuvant chemotherapy was frequently administered but has debatable therapeutic value. These data highlight opportunities to decrease treatment burden in patients with CS IIA nonseminoma." @default.
- W3016947771 created "2020-04-24" @default.
- W3016947771 creator A5055411258 @default.
- W3016947771 creator A5057040034 @default.
- W3016947771 creator A5063790699 @default.
- W3016947771 creator A5083626538 @default.
- W3016947771 creator A5091398645 @default.
- W3016947771 date "2020-08-01" @default.
- W3016947771 modified "2023-10-03" @default.
- W3016947771 title "National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy" @default.
- W3016947771 cites W1584634571 @default.
- W3016947771 cites W1602136144 @default.
- W3016947771 cites W1980318009 @default.
- W3016947771 cites W2018508517 @default.
- W3016947771 cites W2028974865 @default.
- W3016947771 cites W2040184182 @default.
- W3016947771 cites W2104688007 @default.
- W3016947771 cites W2109392790 @default.
- W3016947771 cites W2132274239 @default.
- W3016947771 cites W2146749441 @default.
- W3016947771 cites W2156845043 @default.
- W3016947771 cites W2163970298 @default.
- W3016947771 cites W2211078106 @default.
- W3016947771 cites W2313355799 @default.
- W3016947771 cites W2340182039 @default.
- W3016947771 cites W2480687374 @default.
- W3016947771 cites W2736104174 @default.
- W3016947771 cites W2788036169 @default.
- W3016947771 cites W2795985918 @default.
- W3016947771 cites W2922255797 @default.
- W3016947771 cites W2944394755 @default.
- W3016947771 doi "https://doi.org/10.1016/j.urolonc.2020.03.014" @default.
- W3016947771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32305267" @default.
- W3016947771 hasPublicationYear "2020" @default.
- W3016947771 type Work @default.
- W3016947771 sameAs 3016947771 @default.
- W3016947771 citedByCount "1" @default.
- W3016947771 countsByYear W30169477712023 @default.
- W3016947771 crossrefType "journal-article" @default.
- W3016947771 hasAuthorship W3016947771A5055411258 @default.
- W3016947771 hasAuthorship W3016947771A5057040034 @default.
- W3016947771 hasAuthorship W3016947771A5063790699 @default.
- W3016947771 hasAuthorship W3016947771A5083626538 @default.
- W3016947771 hasAuthorship W3016947771A5091398645 @default.
- W3016947771 hasConcept C126322002 @default.
- W3016947771 hasConcept C141071460 @default.
- W3016947771 hasConcept C143998085 @default.
- W3016947771 hasConcept C146357865 @default.
- W3016947771 hasConcept C151730666 @default.
- W3016947771 hasConcept C2776212926 @default.
- W3016947771 hasConcept C2776611710 @default.
- W3016947771 hasConcept C2776694085 @default.
- W3016947771 hasConcept C2776938808 @default.
- W3016947771 hasConcept C2779511695 @default.
- W3016947771 hasConcept C71924100 @default.
- W3016947771 hasConcept C86803240 @default.
- W3016947771 hasConceptScore W3016947771C126322002 @default.
- W3016947771 hasConceptScore W3016947771C141071460 @default.
- W3016947771 hasConceptScore W3016947771C143998085 @default.
- W3016947771 hasConceptScore W3016947771C146357865 @default.
- W3016947771 hasConceptScore W3016947771C151730666 @default.
- W3016947771 hasConceptScore W3016947771C2776212926 @default.
- W3016947771 hasConceptScore W3016947771C2776611710 @default.
- W3016947771 hasConceptScore W3016947771C2776694085 @default.
- W3016947771 hasConceptScore W3016947771C2776938808 @default.
- W3016947771 hasConceptScore W3016947771C2779511695 @default.
- W3016947771 hasConceptScore W3016947771C71924100 @default.
- W3016947771 hasConceptScore W3016947771C86803240 @default.
- W3016947771 hasIssue "8" @default.
- W3016947771 hasLocation W30169477711 @default.
- W3016947771 hasOpenAccess W3016947771 @default.
- W3016947771 hasPrimaryLocation W30169477711 @default.
- W3016947771 hasRelatedWork W101130268 @default.
- W3016947771 hasRelatedWork W111262356 @default.
- W3016947771 hasRelatedWork W1762438162 @default.
- W3016947771 hasRelatedWork W2033368464 @default.
- W3016947771 hasRelatedWork W2109392790 @default.
- W3016947771 hasRelatedWork W2138245006 @default.
- W3016947771 hasRelatedWork W2164164051 @default.
- W3016947771 hasRelatedWork W2605286958 @default.
- W3016947771 hasRelatedWork W3022045883 @default.
- W3016947771 hasRelatedWork W343392656 @default.
- W3016947771 hasVolume "38" @default.
- W3016947771 isParatext "false" @default.
- W3016947771 isRetracted "false" @default.
- W3016947771 magId "3016947771" @default.
- W3016947771 workType "article" @default.